Viagra (Sildenafil Citrate) 100 mg
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Impotence
Conditions
Impotence
Trial Timeline
Aug 1, 2005 → May 1, 2006
NCT ID
NCT00143260About Viagra (Sildenafil Citrate) 100 mg
Viagra (Sildenafil Citrate) 100 mg is a approved stage product being developed by Pfizer for Impotence. The current trial status is completed. This product is registered under clinical trial identifier NCT00143260. Target conditions include Impotence.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00143260 | Approved | Completed |
| NCT00137072 | Approved | Completed |
Competing Products
20 competing products in Impotence
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| tadalafil | Eli Lilly | Approved | 85 |
| tadalafil + sildenafil | Eli Lilly | Approved | 85 |
| tadalafil + placebo + tadalafil + tadalafil + tadalafil + placebo | Eli Lilly | Phase 3 | 77 |
| GPI 1485 | Eisai | Phase 2 | 52 |
| tadalafil + sildenafil | Eli Lilly | Approved | 85 |
| tadalafil | Eli Lilly | Approved | 85 |
| tadalafil + sildenafil | Eli Lilly | Phase 3 | 77 |
| tadalafil | Eli Lilly | Phase 3 | 77 |
| tadalafil + placebo + tadalafil + tadalafil | Eli Lilly | Phase 3 | 77 |
| tadalafil + Placebo | Eli Lilly | Phase 3 | 77 |
| tadalafil + tadalafil + placebo | Eli Lilly | Phase 3 | 77 |
| tadalafil + tadalafil + placebo | Eli Lilly | Phase 3 | 77 |
| Fluvastatin-sodium | Novartis | Phase 3 | 77 |
| Sildenafil Citrate | Pfizer | Approved | 84 |
| UK0369,003 + Cialis (Tadalafil) | Pfizer | Phase 2 | 51 |
| Viagra (Sildenafil citrate) | Pfizer | Approved | 84 |
| sildenafil citrate | Pfizer | Approved | 84 |
| Placebo + Viagra (sildenafil citrate) | Pfizer | Approved | 84 |
| UK-369,003 | Pfizer | Phase 2 | 51 |
| Viagra (Sildenafil citrate) | Pfizer | Approved | 84 |